We are live on ! Find out more
WC

Woodstock Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 26.37%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.51%
AUM
$614M
AUM Growth
+$40M
Cap. Flow
-$7.96M
Cap. Flow %
-1.3%
Top 10 Hldgs %
29.7%
Holding
164
New
2
Increased
37
Reduced
65
Closed
9

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.57M
2
IRM icon
Iron Mountain
IRM
+$626K
3
MMM icon
3M
MMM
+$589K
4
KYNB
Kyntra Bio
KYNB
+$490K
5
RTN
Raytheon Company
RTN
+$442K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.2M
2
SLB icon
SLB Ltd
SLB
+$1.83M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$1.01M
4
HAIN icon
Hain Celestial
HAIN
+$727K
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$605K

Sector Composition

Rank Sector Weight
1 Healthcare 24.16%
2 Technology 22.86%
3 Industrials 9.44%
4 Consumer Staples 8.89%
5 Communication Services 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCD icon
51
McDonald's
MCD
$195B
$3.89M 0.63%
19,681
-185
-0.9% -$36.7K
PNC icon
52
PNC Financial Services
PNC
$102B
$3.65M 0.59%
22,862
-525
-2% -$78.8K
UPS icon
53
United Parcel Service
UPS
$91.5B
$3.52M 0.57%
30,096
-150
-0.5% -$17.8K
SYK icon
54
Stryker
SYK
$129B
$3.45M 0.56%
16,443
-60
-0.4% -$12.5K
CB icon
55
Chubb
CB
$136B
$3.29M 0.54%
21,121
+20
+0.1% +$3.06K
KO icon
56
Coca-Cola
KO
$374B
$3.23M 0.53%
58,319
+100
+0.2% +$5.38K
RETA
57
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3.09M 0.5%
15,109
-5,515
-27% -$1.01M
SLB icon
58
SLB Ltd
SLB
$74.1B
$3.03M 0.49%
75,272
-51,358
-41% -$1.83M
KMB icon
59
Kimberly-Clark
KMB
$37.3B
$2.77M 0.45%
20,151
+75
+0.4% +$10.1K
HBI
60
DELISTED
Hanesbrands
HBI
$2.71M 0.44%
182,741
-6,390
-3% -$97.1K
NVEE
61
DELISTED
NV5 Global
NVEE
$2.52M 0.41%
199,632
– –
BRK.B icon
62
Berkshire Hathaway Class B
BRK.B
$1.12T
$2.48M 0.4%
10,928
+930
+9% +$202K
AGN
63
DELISTED
Allergan plc
AGN
$2.44M 0.4%
12,781
-1,499
-10% -$270K
ENB icon
64
Enbridge
ENB
$113B
$2.38M 0.39%
59,827
-1,411
-2% -$52.7K
CL icon
65
Colgate-Palmolive
CL
$74.4B
$2.37M 0.39%
34,471
-400
-1% -$27.3K
EFA icon
66
iShares MSCI EAFE ETF
EFA
$79.4B
$2.18M 0.36%
31,390
– –
ADI icon
67
Analog Devices
ADI
$184B
$2.04M 0.33%
17,148
+927
+6% +$104K
RDS.B
68
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.98M 0.32%
33,091
+750
+2% +$44.2K
OXY icon
69
Occidental Petroleum
OXY
$53.5B
$1.97M 0.32%
47,734
+6,039
+14% +$242K
AMGN icon
70
Amgen
AMGN
$220B
$1.92M 0.31%
7,945
+50
+0.6% +$11K
TSCO icon
71
Tractor Supply
TSCO
$17.5B
$1.79M 0.29%
95,895
-5,000
-5% -$94.9K
GD icon
72
General Dynamics
GD
$104B
$1.73M 0.28%
9,827
+1,750
+22% +$314K
FLS icon
73
Flowserve
FLS
$10.1B
$1.73M 0.28%
34,750
+2,300
+7% +$110K
BNY
74
Bank of New York Mellon
BNY
$108B
$1.66M 0.27%
33,057
-4,158
-11% -$198K
D icon
75
Dominion Energy
D
$60B
$1.63M 0.26%
19,629
-303
-2% -$24.8K
1 2
3
4 5

Similar funds

SGDR
SPX Gestao de Recursos Rio De Janeiro, Brazil $1.2B AUM 59.05% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.21B AUM
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return

Woodstock Corp's Q4 2019 Portfolio in Review

As of Q4 2019, Woodstock Corp held 164 positions worth $614M, up 7% from $574M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Woodstock Corp's Q4 2019 filing shows 2 new, 37 increased, 65 reduced and 9 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 90,585 shares worth $273K. The largest sale was Celgene Corp, an estimated $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Woodstock Corp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 90,585 shares worth $273K.
  • Woodstock Corp added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.57M increase.
  • Woodstock Corp's biggest Q4 2019 reduction was SLB Ltd, cutting an estimated $1.83M.
  • Woodstock Corp fully exited Celgene Corp in Q4 2019, selling an estimated $9.2M.
  • Woodstock Corp's ten largest holdings make up 30% of its $614M portfolio in Q4 2019.
  • Woodstock Corp opened 2 new positions and closed 9 in Q4 2019.
  • Woodstock Corp's portfolio value rose 7% quarter-over-quarter to $614M.

Based on Woodstock Corp's 13F filing for Q4 2019, filed 13 Jan 2020.